What does proceeds from sale of notes receivable mean?

This represents the cash inflows received from the sale or liquidation of notes receivable held by the company. It indicates the company's ability to convert non-core financial assets into immediate liquidity. Investors analyze this to evaluate the company's strategy for managing its financial asset portfolio and generating supplemental cash.

Anika Therapeutics ANIK Proceeds From Sale Of Notes Receivable

Proceeds From Sale Of Notes Receivable at other companies

Ingram MicroINGM

$10.18M-7.4%

Legacy Housing CorporationLEGH

$202K+1,088%

Anika TherapeuticsANIK

$192K—

Graphic Packaging HoldingGPK

$137M+136%

Eastern CompanyEML

$5K-65.6%

Utz BrandsUTZ

$1.5M+200%

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfNotesReceivable.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's proceeds from sale of notes receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's proceeds from sale of notes receivable?: Anika Therapeutics (ANIK) reported proceeds from sale of notes receivable of $192K in Q1 2026.
What does proceeds from sale of notes receivable mean?: This represents the cash inflows received from the sale or liquidation of notes receivable held by the company. It indicates the company's ability to convert non-core financial assets into immediate liquidity. Investors analyze this to evaluate the company's strategy for managing its financial asset portfolio and generating supplemental cash.